Streetbeat News

IVP

Inspire Veterinary Partners, Inc.

https://inspirevet.com

Industry

Personal Products & Services

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States. The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds. Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services. The company also provides surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services. Inspire Veterinary Partners, Inc. was incorporated in 2020 and is based in Virginia Beach, Virginia.

Open

0.26

Mkt cap

6.5M

Volume

3.5M

High

0.27

P/E Ratio

-0.07

52-wk high

90.00

Low

0.24

Div yield

N/A

52-wk low

0.23

During Tuesday's intraday session, several healthcare stocks experienced significant movements. Fresh2 Group, Inspire Veterinary, Brainstorm Cell, Leap Therapeutics, Tivic Health Systems, and Immuneering saw their stocks rise by 18.27% to 28.4%. On the other hand, LogicMark, Connect Biopharma Hldgs, NanoString Technologies, MorphoSys, Acutus Medical, and Fortress Biotech faced declines ranging from 21.07% to 42.7%. The movements were accompanied by notable trading volumes, with some companies trading at several times their average full-day volume. MorphoSys's decline followed its Q3 earnings release four days prior.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 5:31 pm

Inspire Veterinary Partners reported a 42% increase in total revenue for Q3, reaching $4.1M compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 10:33 pm

In Tuesday's after-market session, several healthcare stocks experienced significant movements. Theseus Pharmaceuticals (THRX) saw a 34.1% increase, while PaxMedica (PXMD) rose by 19.87%. 180 Life Sciences (ATNF) went up by 17.94% following their Q3 earnings release 3 days prior. Exagen (XGN) and Renalytix (RNLX) also saw gains after their recent earnings reports. Spero Therapeutics (SPRO) increased by 8.1% post Q3 earnings. Conversely, Harrow (HROW) dropped by 22.1%, Tenax Therapeutics (TENX) by 15.89%, Beyond Air (XAIR) by 13.8%, Owlet (OWLT) by 12.55%, TRACON Pharma (TCON) by 10.15%, and Inspire Veterinary (IVP) by 9.8% after their earnings reports.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 9:31 pm

After Monday's after-market session, several healthcare stocks experienced significant movements. Gainers included 180 Life Sciences (ATNF), Kronos Bio (KRON), Monopar Therapeutics (MNPR), Azenta (AZTA), PaxMedica (PXMD), and Spero Therapeutics (SPRO), with increases ranging from 6.3% to 15.8%. Losers were Harrow (HROW), Beyond Air (XAIR), Senti Biosciences (SNTI), Inspire Veterinary (IVP), Owlet (OWLT), and Hepion Pharmaceuticals (HEPA), with declines between 8.22% and 23.9%. Earnings reports were a common driver of these movements.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 9:31 pm

During Tuesday's after-market session, several health care stocks experienced significant movement. Biocept (BIOC), Intelligent Bio Solutions (INBS), RVL Pharmaceuticals (RVLP), Virpax Pharmaceuticals (VRPX), Exagen (XGN), and PaxMedica (PXMD) saw their shares rise, while Athersys (ATHX), Eiger BioPharmaceuticals (EIGR), China SXT Pharmaceuticals (SXTC), Ultragenyx Pharmaceutical (RARE), Bio-Rad Laboratories (BIO), and Inspire Veterinary (IVP) experienced a decline in their stock prices.

Portfolio Pulse from Benzinga Insights

October 17, 2023 | 9:31 pm

On Tuesday, 132 companies hit new 52-week lows. Among them, Corning (NYSE:GLW) was the largest in terms of market cap, while Wheeler Real Estate IT (NASDAQ:WHLR) was the smallest. Fortress Biotech (NASDAQ:FBIO) saw the largest move with shares plummeting 1350.03%, while Insulet (NASDAQ:PODD) made the biggest bounce back, moving up 0.0% shortly after hitting a new 52-week low.

Portfolio Pulse from Benzinga Insights

October 10, 2023 | 5:09 pm

The article reports on the stock movements in Thursday's mid-day session. Notable gainers include MSP Recovery, Near Intelligence, Murphy Canyon Acquisition, TradeUP Acquisition, Neptune Wellness, Inspire Veterinary Partners, Splunk, Solowin Holdings, AgriFORCE Growing Systems, Movella Holdings, Safe & Green Holdings, The Dixie Group, Calliditas Therapeutics, Applied Molecular Transport, Ainos, and Exscientia. Notable losers include Travere Therapeutics, Seelos Therapeutics, QuantaSing Group, Cazoo Group, Cheche Group, Comera Life Sciences, Mondee Holdings, TKO Group Holdings, Opendoor Technologies, TransCode Therapeutics, LanzaTech Global, WM Technology, CF Acquisition, WW International, ZipRecruiter, 36Kr Holdings, Evotec, Avinger, fuboTV, Affirm Holdings, Charles River Laboratories, Elutia, and Broadcom.

Portfolio Pulse from Lisa Levin

September 21, 2023 | 5:16 pm

Inspire Veterinary Partners (IVP) has announced its intention to acquire a 100% ownership interest in a Pennsylvania animal hospital. This has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 2:16 pm

Inspire Veterinary Partners (IVP) has announced a non-binding letter of intent to acquire 100% ownership in an animal hospital in Pennsylvania. This acquisition, expected to close in October 2023, will add one new animal hospital to IVP's existing network of 13 animal hospitals and mark its entry into Pennsylvania. The company also has an active pipeline of attractive acquisitions to be announced in 2023.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:36 pm

Several stocks experienced significant price movements in Tuesday's mid-day session. Tenon Medical withdrew its proposed public offering, causing its shares to climb 63.5%. Avalo Therapeutics agreed to divest AVTX-800 series, leading to a 52.6% gain. Cognyte Software reported better-than-expected Q2 results and issued FY24 guidance above estimates, resulting in a 24.8% gain. Xos was awarded a contract by the State of California, causing a 23% gain. The Beauty Health Company announced a business transformation program and a $100 million share repurchase, leading to a 16.6% jump. On the other hand, Acelyrin shares fell 60.8% after announcing disappointing trial results. CS Disco shares fell 22.1% after the company announced its CEO's departure.

Portfolio Pulse from Lisa Levin

September 12, 2023 | 5:44 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.